Search results for "OSiS"

showing 10 items of 15931 documents

Bisphosphonate treatment and dental implants: A systematic review

2015

Background To analyze articles that studied patients submitted to diphosphonates therapy and who received dental implants before, during or after bisphosphonate (BP) treatment, compared to healthy patients, analyzing the increase of failure and loss of implants or bisphosphonate related osteonecrosis of the jaw (BRONJ) incidence. Material and Methods The Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) statement was used in this study. The clinical question in “PICO” format was: In patients under bisphosphonate therapy, do dental implants placement, compared to healthy patients, increase the failure and loss of implants or bisphosphonate related osteonecrosis of t…

medicine.medical_specialtymedicine.medical_treatmentMEDLINEDentistryReview03 medical and health sciences0302 clinical medicinestomatognathic systemmedicineHumansProspective StudiesProspective cohort studyGeneral DentistryRetrospective StudiesDental ImplantsBone Density Conservation AgentsDiphosphonatesbusiness.industryIncidence (epidemiology)DiphosphonatesRetrospective cohort study030206 dentistryBisphosphonate:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseSurgerystomatognathic diseasesBone Density Conservation AgentsOtorhinolaryngology030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASSurgeryOral SurgerybusinessOsteonecrosis of the jawMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Simple bone cyst : description of 60 cases seen at a Brazilian School of Dentistry and review of international literature

2020

Background The aim of this study was to describe the relative frequency and the main demographic and clinic-radiographic features related to patients diagnosed with Simple bone cyst (SBC) in an Oral Diagnosis Service in Southeast Brazil and present a review and discussion of international literature on this topic. Material and Methods SBC cases from our service encompassing the period between 1978 and 2017 were selected. In addition, a literature search was performed in the Pubmed/MEDLINE online electronic database published between 1951 and 2019. Results A total of 2,459 cystic lesions were documented in our service, thus 60 patients were diagnosed with the SBC representing 2.4% of all jaw…

medicine.medical_specialtymedicine.medical_treatmentMEDLINEOdontogenic TumorsMandibleAsymptomatic03 medical and health sciences0302 clinical medicinemedicineInternational literatureBone CystsHumansOral DiagnosisGeneral DentistryOral Medicine and PathologySchoolsbusiness.industryGeneral surgerySimple Bone CystResearch030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]CurettageOtorhinolaryngologyDysplasiaUNESCO::CIENCIAS MÉDICASSurgeryFemaleElectronic databasemedicine.symptombusinessBrazil
researchProduct

Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion

2021

Introduction Inappropriate insulin secretion could be due to several diseases. Nesidioblastosis is characterized by diffuse hyperplasia of pancreatic beta cells, causing organic hypoglycemia. No pancreatic lesions are found on the imaging of patients with this condition. Diazoxide is used as a first-line treatment but can be poorly tolerated because of its side effects, and therapeutic failure is possible. Somatostatin analogues have limited efficacy because of their poor affinity to somatostatin (SST) receptors. Pasireotide is a somatostatin analogue with a much higher affinity to SST receptors, especially SST5, and it could thus be more efficient for treating nesidioblastosis-related hypo…

medicine.medical_specialtymedicine.medical_treatmentNesidioblastosisOctreotideCase ReportHypoglycemiaGastroenterologychemistry.chemical_compoundInternal medicinemedicineDiazoxidePharmacology (medical)business.industryInsulinnutritional and metabolic diseasesmedicine.diseasenesidioblastosisPasireotidediazoxideSomatostatinhypoglycemiachemistrySitagliptinpasireotide LARbusinessmedicine.drugClinical Pharmacology : Advances and Applications
researchProduct

Prevalence of Vertebral Fractures and Their Prognostic Significance in the Survival in Patients with Chronic Kidney Disease Stages 3‒5 Not on Dialysis

2020

Background: The prevalence of vertebral fractures (VF) and their association with clinical risk factors and outcomes are poorly documented in chronic kidney disease (CKD) cohorts. The aim of the study was to evaluate the prevalence of VF in patients with non-dialysis dependent CKD (NDD-CKD), their value in predicting mortality and its correlation with parameters of bone mineral metabolism and vascular calcification. Materials and Methods: 612 NDD 3‒5 stage CKD patients participating in the OSERCE-2 study, a prospective, multicenter, cohort study, were prospectively evaluated and categorized into two groups according to presence or absence of VF at enrollment. VF were assessed with lateral r…

medicine.medical_specialtymedicine.medical_treatmentOsteoporosis030232 urology & nephrologylcsh:Medicine030209 endocrinology & metabolismLogistic regressionArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicineRisk factorSurvival analysisDialysisVascular diseasebusiness.industrylcsh:RGeneral Medicinefracturesmedicine.diseasevascular calcificationbusinesschronic kidney diseaseCohort studyKidney diseaseJournal of Clinical Medicine
researchProduct

Real-world Adherence and Persistence with Bisphosphonate Therapy in Postmenopausal Women: A Systematic Review

2018

Abstract Purpose Bisphosphonate therapy is a well-established and effective treatment for postmenopausal osteoporosis and the prevention of osteoporotic fracture. However, poor adherence to and poor persistence with bisphosphonate therapy may reduce its benefits. Previous studies have documented the poor rates of adherence and persistence among postmenopausal women with osteoporosis. The objective of this systematic literature review was to evaluate adherence, persistence, and the impact of adherence and persistence on fracture risk in postmenopausal women with diagnosed osteoporosis. Methods Articles eligible for review included observational studies of the real-world use of bisphosphonate…

medicine.medical_specialtymedicine.medical_treatmentOsteoporosisMEDLINE02 engineering and technology030204 cardiovascular system & hematologyMedication AdherencePersistence (computer science)03 medical and health sciences020210 optoelectronics & photonics0302 clinical medicineInternal medicine0202 electrical engineering electronic engineering information engineeringmedicineHumansPharmacology (medical)Osteoporosis PostmenopausalPharmacologyBone Density Conservation AgentsDiphosphonatesbusiness.industryBisphosphonatemedicine.diseasePostmenopauseMenopauseObservational Studies as TopicTreatment OutcomeSystematic reviewFemaleObservational studybusinessOsteoporotic FracturesBiomedical sciencesClinical Therapeutics
researchProduct

Dental implants in patients treated with oral bisphosphonates. A bibliographic review

2010

Bisphosphonates inhibit bone resorption and are used to treat a range of pathologies, including Paget disease, osteoporosis, multiple myeloma and metastases associated with breast or prostate cancer. At present, there is no effective treatment for bisphosphonate induced osteonecrosis, so prevention is extremely important. Since quality of life deteriorates for those suffering osteonecrosis, maximum precautions should be taken with patients at risk, and especially whenever oral surgery, including dental implant placement, is contemplated. Dentists and oral or maxillofacial surgeons must keep up to date with the latest approaches to prevention, particularly when treating patients who are pres…

medicine.medical_specialtymedicine.medical_treatmentOsteoporosisMEDLINEAdministration OralDentistryBone resorptionProstate cancerQuality of lifemedicineHumansDental implantGeneral DentistryMultiple myelomaDental ImplantsDiphosphonatesbusiness.industryOsteonecrosisBisphosphonatemedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgerybusinessJaw Diseases
researchProduct

Proposal for a preventive protocol for medication-related osteonecrosis of the jaw.

2021

Background Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse reaction experienced by some patients exposed to certain drugs (antiresorptives such as bisphosphonates or denosumab, and antiangiogenic drugs). From a review of the literature it appears that there is no uniform criterion when selecting preventive measures; these vary according to author. Likewise, the measures recommended are usually general, so that in few cases they result in specific actions to be applied depending on the different variables involved such as the type of drug used, the duration of its application, the underlying pathology, the presence or absence of risk factors, etc. The aim of this stud…

medicine.medical_specialtymedicine.medical_treatmentOsteoporosisMEDLINEReviewsleep disturbancesolder people03 medical and health sciences0302 clinical medicinemedicineHumansIntensive care medicineAdverse effectDental implantGeneral DentistryUNESCO:CIENCIAS MÉDICASProtocol (science)dental implantOral Medicine and PathologyedentulismBone Density Conservation AgentsDiphosphonatesbusiness.industryOsteonecrosis030206 dentistrymedicine.diseaseDenosumabSystematic reviewOtorhinolaryngologyOsteoporosisSurgeryBisphosphonate-Associated Osteonecrosis of the JawbusinessOsteonecrosis of the jawmedicine.drug
researchProduct

Surgical treatment vs. conservative treatment in intravenous bisphosphonate-related osteonecrosis of the jaws. Systematic review

2017

AIMS To determine the success rates of the surgical and non-surgical treatments in the management of bisphosphonate-related osteonecrosis of the jaws (BRONJ). MATERIAL AND METHODS A systematic review of the literature was made. A PubMed Medline database search was performed in order to include clinical studies published in English,between2004 and 2014 with the following key-words: "BRONJ AND treatment" and "NOT osteoporosis". The following data was gathered: authors, title, year of publication, aim of study, level of evidence, sample size, treatment performed, treatment outcomes and follow-up. Studies including more than 20 patients with at least 6 months of follow-up, and that specify the …

medicine.medical_specialtymedicine.medical_treatmentOsteoporosisOdontologíaJawsReviewlaw.invention03 medical and health sciencesNecrosis0302 clinical medicineRandomized controlled triallawmedicineGeneral DentistryOral Medicine and PathologyMaxil·larsbusiness.industryGeneral surgery030206 dentistryEvidence-based medicineBisphosphonatemedicine.disease:CIENCIAS MÉDICAS [UNESCO]NecrosiCiencias de la saludSurgeryConservative treatmentSystematic reviewSequestrectomySample size determination030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASbusiness
researchProduct

Improved femoral neck BMD in older Finnish women between 2002 and 2010.

2013

Abstract Purpose The number of hip fractures among Finns over 50-years of age rose constantly between 1970 and 1997, but since then, there has been a nationwide decline in incidence of hip fractures. One possible explanation, although not the only one, for the declining fracture rates, could be improved bone mineral density (BMD). The aim of this study was to evaluate differences in femoral neck BMD between older Finnish women born about a decade apart. Methods We compared the baseline data of two population-based samples of home-dwelling 70–80-year-old women who were initially recruited in exercise intervention studies ( N  = 216 in Cohort1, and N  = 389 in Cohort 2). Femoral neck BMD was …

medicine.medical_specialtymedicine.medical_treatmentOsteoporosisPopulationGeneral Biochemistry Genetics and Molecular BiologyCohort StudiesBone DensitymedicineHumanseducationFinlandOsteoporosis PostmenopausalFemoral neckAgedBone mineralAged 80 and overeducation.field_of_studyAnalysis of Variancebusiness.industryFemur NeckHip FracturesIncidence (epidemiology)IncidenceAge FactorsObstetrics and Gynecologyta3141Baseline datamedicine.diseaseBody Heightmedicine.anatomical_structureCohortPhysical therapyFemaleHormone therapybusinessDemographyMaturitas
researchProduct

Ovarian cysts in newborns.

2001

Before the introduction of ultrasonography (US), ovarian cysts in newborns were thought to be rare. With the extended use of real-time US, prenatal detection has increased. There is still considerable controversy regarding the best treatment of these neonatal findings. A total of 27 instances in 24 consecutive newborns of antenatally-diagnosed ovarian cysts were reviewed for US data, management, and outcome to assess the ante- and postnatal evolution of the cyst and establish appropriate therapy. The cysts detected during pregnancy were studied by repeated postnatal US studies. In 10 children (2 with bilateral cysts) the cyst evolved spontaneously toward regression. Fourteen patients were o…

medicine.medical_specialtymedicine.medical_treatmentOvariectomyOvaryPrenatal diagnosisUltrasonography PrenatalCystectomyLesionparasitic diseasesPediatric surgerymedicineHumansCystPregnancybusiness.industryCesarean SectionOvaryInfant NewbornOophorectomyGeneral Medicinemedicine.diseaseSurgeryOvarian Cystsmedicine.anatomical_structurePediatrics Perinatology and Child HealthSurgeryFemalemedicine.symptombusinessPediatric surgery international
researchProduct